N/A
N=60
Effect of Super-Oxygenated Water on Blood Oxygen Saturation
Adult Subject
Bottom Line
View on ClinicalTrials.gov: NCT07016191 ↗Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Jan 2026
Primary outcome: Primary: SpO2 Response Rate — 21; 11 Participants — p=0.010
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Ingestion of Water (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Inhale, Inc
- Primary completion
- Nov 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY SpO2 Response Rate |
21; 11 | 0.010 sig |
| PRIMARY Heart Rate Response Rate |
21; 14 | 0.067 |
| SECONDARY Energy Level Response Rate |
17; 6 | 0.003 sig |
| SECONDARY Brain Clarity Response Rate |
15; 5 | 0.006 sig |
Summary
Therapeutic delivery of additional Oxygen to blood stream via hyperbaric and extracorporeal oxygenation that raises blood Oxygen saturation level, apart from oxygenation in the lungs, is known to induce tissue repair, restore normal body functions and improve survival. Despite the clinical benefits obtained from these interventions, Oxygen supplementation is rather a medically involved process requiring access to specialized equipment including hyperbaric chambers, cardiac catheterization laboratory and extracorporeal oxygenators, and is not generally amenable for everyday use. The current prospective study will evaluate a non-invasive route for Oxygen delivery through ingestion of super-oxygenated water in adult volunteers. The participants will be randomly assigned to one of the two study groups viz. Inhale super-oxygenated water or placebo control normal water at 1:1 ratio. Neither the participants nor the study doctor will know the treatment assignment. Pre- and post-ingestion measurements will be conducted to evaluate effect of super-oxygenated water.
Eligibility Criteria
Inclusion Criteria
- Legally adult (18 years of age or older)
- Subject must be willing to review and provide a written informed consent
- Subject must agree to the study procedures including water ingestion, and SPO2 and heart rate measurements
Exclusion Criteria
- Any active and life-threatening medical condition involving hepatic, renal, cardiac, respiratory, endocrine, or gastrointestinal systems, or any blood disorder in view of the Principal Investigator to confound the study
- Female subjects those are pregnant, nursing or planning to become pregnant
- Subjects receiving any experimental medications or have undergone a major surgical procedure in last 30 days
- Subjects are excluded if they have previously utilized the test article (INHALE superoxygenated water) within the last 24 hours, or have undergone bariatric surgery or have received weight-loss medication
- Subjects with known anemia, hemoglobinopathy or other comorbidity necessitating fluid restriction
Data sourced from ClinicalTrials.gov (NCT07016191). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.